FDA Inspection
Altaire Pharmaceuticals, Inc.FDA Inspection 1314330 - Altaire Pharmaceuticals, Inc. - April 21, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Altaire Pharmaceuticals, Inc., with an inspection on April 21, 2026, issued by the New York District Office, covering human drugs.
- Office
- New York District Office
Open in Dashboard
ID · 41e19a6e-ba33-47a8-ad24-842a94d518b4
Violation Codes8
21 CFR 211.100(a)21 CFR 211.113(b)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)21 CFR 211.68(b)
Full citation text and observation details available on the Dashboard.